Skip to main content

Books in Life sciences

Elsevier's Life Sciences collection helps researchers get comprehensive coverage and up-to-date information on the study of living organisms, their processes, and interrelationships, spanning disciplines like biology, genetics, and biochemistry, and addressing emerging trends such as genomics, biotechnology, and sustainability, essential for advancing knowledge and driving innovation in the field.

    • Nuclear Proteins

      • 1st Edition
      • Volume 143
      • January 23, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 2 9 5 6 4 5
      • eBook
        9 7 8 0 4 4 3 2 9 5 6 5 2
      Advances in Protein Chemistry and Structural Biology, Volume 143 in the series, covers reviews of methodology and research in all aspects of protein chemistry, including purification/express... proteomics, modeling and structural determination and design. Chapters in this new release include Therapeutic insight into the role of nuclear protein HNF4α in liver carcinogenesis, Structural mechanism of nucleoporins in cancer disease, Identification of nuclear matrix proteins (novel genes) in bladder cancer using Bioinformatic approaches, A comparative study of nuclear proteins of different cancers - A systematic review, Role of lamins in cellular physiology and cancer, and much more.Other chapters cover Nuclear Hormone Receptors as Drug Targets: Advancements and Future Prospects, Proteins binding to tandemly repeated DNA: familiar strangers, HMGB1, R-loops and genome stability, Nuclear tau accumulation in Alzheimer's Disease, and Histone deacetylase's (HDACs) regulates Tau function in Alzheimer's Disease.
    • Applications of Biosensors in Healthcare

      • 1st Edition
      • January 23, 2025
      • Md Saquib Hasnain + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 1 5 9 2 6
      • eBook
        9 7 8 0 4 4 3 2 1 5 9 3 3
      Applications of Biosensors in Healthcare: Volume 3 details and explores the various ways biosensors are used in healthcare, disease management, and therapeutic delivery.This is the third volume out of three volumes covering biosensors in healthcare. The volume discusses various types of biosensors and their use in diagnostics, health monitoring, disease detection, and therapeutic delivery. Combined with the Volume 1, Fundamentals of Biosensors in Healthcare, and Volume 2, Applications of Biosensors in Healthcare, the volumes provide a holistic reference source suitable for researchers, graduate students, postgraduates, and industry professionals involved in biosensing, biosensors, and biomedical applications.
    • Profiles of Drug Substances, Excipients, and Related Methodology

      • 1st Edition
      • Volume 50
      • January 23, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 3 4 4 8 3 1
      • eBook
        9 7 8 0 4 4 3 3 4 4 8 4 8
      Profiles of Drug Substances, Excipients, and Related Methodology, Volume 50 includes comprehensive profiles of four drug compounds: Sofosbuvir, Nateglinide, Linagliptin, and Dronedarone, providing comprehensive knowledge on their physical and chemical properties, synthesis and degradation pathways, analytical techniques for identification and quantification, separation methods, and pharmacology of drug substances. Finally, this volume includes a review article related to the Applications of Cyclodextrins in Pharmaceutical and Related Fields, along with a chapter on Fenamates Degradation. This information is highly valuable to professionals in the field, but having it all in one place is a great benefit to readers.The Profiles series encompasses five review articles and database compilations on various topics, including the physical profiles, analytical profiles, ADME profiles, methodologies related to the characterization, and methods of chemical synthesis of drug substances and excipients.
    • Coffee

      • 1st Edition
      • Volume 114
      • January 23, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 2 2 2 9 4 8
      • eBook
        9 7 8 0 4 4 3 2 2 2 9 5 5
      Coffee, Volume 112 gives the latest updates on one of the premier global traded commodities. With its annual income of approx. USD 200 billion, it supports the livelihoods of nearly 25 million smallholder farmers. In this updated edition, chapters cover The history and genetic diversity of arabica coffee, The importance of wild coffee species in a scenario of climate changes, Coffee plant architecture, Water and heat constraints to coffee ecophysiology and production, The impacts of irradiance on coffee growth and ecophysiology in a context of climate changes, Omic technologies contribution to unveil coffee resilience responses to climate changes, and much more.Additional chapters delve into Agroforestry as an alternative management system to improve coffee crop sustainability and bean quality, Could breeding of new arabica coffee varieties be a response to the climate change?, Selection, development, and management of robusta coffee genotypes under a climate change perspective, Grafting coffee for productivity and health during a changing climate, Coffee somatic embryogenesis: advances, limitations, and perspectives for mass propagation, and many other topics.
    • Microbiota-Gut-Brain Axis and CNS Disorders

      • 1st Edition
      • January 21, 2025
      • Neeraj Mishra + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 1 6 8 0 0
      • eBook
        9 7 8 0 4 4 3 2 1 6 8 1 7
      Microbiota-Gut-Brain Axis and CNS Disorders: Recent Progress and Perspectives on Human Disease summarizes the main findings on gut-brain axis in different types of CNS disorders, providing a complete overview of the field. The content helps unravel the complex interactions of the microbiota-gut-brain... in CNS disorders to pave a better understanding of microbiota-mediated pathogenesis, avenues for noninvasive prognosis, and therapeutic possibilities leveraging microbiota-gut-brain... modulations. Coverage includes the role of the microbiota-gut-brain axis and gut virome on human diseases including Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Depression and Anxiety, Autism Spectrum Disorder, Multiple Sclerosis, Stroke, and others.This book will satisfy the urgent need for a broader view of the current associations between gut microbiota alterations and development of CNS disorders, including the use of novel therapeutic approaches for restoring the correct intestinal bacteria content. It is the perfect reference for translational and clinical gut and microbiome researchers tackling the challenges of delivering genes and drugs in a more targeted and efficient manner for the treatment of CNS disorders.
    • Fundamentals of AI for Medical Education, Research and Practice

      • 1st Edition
      • January 20, 2025
      • Sameer Mohommed Khan
      • English
      • Paperback
        9 7 8 0 4 4 3 3 3 5 8 4 6
      • eBook
        9 7 8 0 4 4 3 3 3 5 8 5 3
      Fundamentals of AI for Medical Education, Research and Practice provides a comprehensive introduction on all aspects of AI application in healthcare, ranging from medical education to diagnostic medicine. The book's chapters are grouped into six sections: an introduction to AI in healthcare, AI in medical education, AI healthcare in research, AI in clinical practice, and future directions and challenges, concluding with practical application of AI tools in health care. Written by an experienced physiologist and medical educationist who is actively involved in all aspects of teaching and learning, this book will prove to be immense benefit for medical researchers, practicing clinicians, academicians and medical students at all levels.
    • Translational Cardiology

      • 1st Edition
      • January 20, 2025
      • Jeffrey A. Bakal + 2 more
      • English
      • Paperback
        9 7 8 0 3 2 3 9 1 7 9 0 2
      • eBook
        9 7 8 0 3 2 3 9 8 6 1 0 6
      Translational Cardiology provides a cardiology-specific instructional guide to translational medical research that will serve as a practical, step-by-step roadmap for taking a biomedical device, potential therapeutic agent, or research question from idea through demonstrated clinical benefit. Fundamentally, the volume aims to help bridge the gap between current research and practice. Written by a team of expert medical, biomedical engineering, and clinical research experts in cardiology, this book provides a clear process for understanding, designing, executing, and analyzing clinical and translational research.
    • CRISPR-Cas-Based Genome Editing for Treating Human Diseases - Part B

      • 1st Edition
      • Volume 210
      • January 18, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 2 2 4 2 0 1
      • eBook
        9 7 8 0 4 4 3 2 2 4 2 1 8
      CRISPR-Cas-Based Genome Editing for Treating Human Diseases, Part B represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems have been proven to be a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. Chapters in this release include Current approaches in CRISPR –Cas systems for metabolic disorders, Recent progress in CRISPR –Cas systems for CRISPR for retinal diseases, Recent progress in CRISPR –Cas systems for cataract and blindness, Advances in CRISPR –Cas systems for muscular dystrophy, Recent development in CRISPR –Cas systems for cardiac disease, Current approaches in CRISPR –Cas systems for diabetes, and much more.Additional sections cover Advances in CRISPR –Cas systems for liver disease, Advances in CRISPR –Cas systems for lung disease, Advances in CRISPR –Cas systems for kidney diseases, Current progress in CRISPR –Cas systems for rare disease, Advances in CRISPR –Cas systems for heredity disease, Recent progress in CRISPR –Cas systems for neurological disorders, and CRISPR challenges in clinical developments.
    • Grapevine

      • 1st Edition
      • Volume 113
      • January 16, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 2 2 1 7 5 0
      • eBook
        9 7 8 0 4 4 3 2 2 1 7 7 4
      Grapevine: Added-Value and Applications, Volume 111 in the Advances in Botanical Research series, highlights new advances in the field, with this new volume presenting interesting chapters on exciting and timely topics such as Biorefinery based bioproducts and future prospective of vineyard and winery waste, Side-streams of wine industry: insights and learned lessons for making real the vision of reliable pharmacological applications, Grapevine as a natural resource in the cosmetic industry, Biology of the main grapevine viruses and their effects on vine growth, yield, and grape chemical composition, Table grapes: Health implications and approaches to improve the quality during the cultivation, and more.Additional sections cover topics such as Controlling authenticity throughout the wine production chain and Wine consumption versus health: the dilemma.
    • Immuno-oncology and immunotherapy Part C

      • 1st Edition
      • Volume 191
      • January 16, 2025
      • English
      • Hardback
        9 7 8 0 4 4 3 2 9 6 2 0 8
      • eBook
        9 7 8 0 4 4 3 2 9 6 2 1 5
      Immuno-oncology and immunotherapy, Part C, Volume 191 in the Methods in Cell Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Extraction and quantification of histones from human cells, Expression and characterization of Phosphatidylserine-t... antibodies for biochemical and therapeutic applications, ILC differentiation from HSCs in vitro, Methods to expand human Treg cells and assay their function, Monitoring rapid activation of human gamma/delta T cells by multicolor flow cytometry, Methods to induce T cell exhaustion in vitro, Ex vivo assessment of human neutrophil motility and migration, and much more.Additional chapters focus on Flow cytometry-based monitoring of myeloid-derived suppressor cells in the peripheral blood of patients with solid tumors, Deciphering human blood and tumor neutrophil heterogeneity: Methods for isolation and assessing suppression of T-cell proliferation, Splenocyte anticancer citotoxicity assessment after prophylactic vaccination or drug treatment of tumor-bearing mice, Therapeutic treatment of tumor-bearing mice with drug-killed cancer cells: a method to confirm immunogenic cell death and assess its therapeutic effectiveness, and much more.